Mesa Laboratories, a global leader in life science tools, will release its financial results for the fourth quarter and full fiscal year ending March 31, 2026, on May 27, 2026. This announcement is important for investors tracking the company's performance in pharmaceutical and healthcare quality control markets. The results will provide insights into Mesa's business health and future prospects under its new CEO Siddhartha Kadia, appointed earlier in 2026.
A new patent application reveals a quantum AI project creating humanoid robots that can carry a person's 'digital DNA' to live alongside humans for centuries. This technology, part of a federally registered clinical trial, allows families to preserve...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging the company may have provided misleading business information to investors in its stock-based mutual funds. Investors who purchased Pu...
CoreWeave secured a $35 billion deal with Meta, making Meta one of its largest customers through 2032. Despite this significant partnership, CoreWeave's shares fell following news related to Meta's own cloud services. The drop suggests investor conce...
Bitcoin price hovered around $64,150 after US President Donald Trump paused military strikes on Iran, reducing immediate escalation risk. Despite this, geopolitical tensions persist with ongoing diplomatic talks and regional conflicts, keeping pressu...
Coinbase has introduced a new feature allowing users to instruct AI agents to automatically buy Ethereum if its price drops by 5%, turning simple commands into rule-based limit orders executed by the exchange. This automation helps users react to mar...
